Patient Registry Software Market by Disease (Diabetes, Cancer, Rare, Asthma, Kidney), Product (Drugs, Device), Use Case (Population Health, Research), End User [(Profit: Pharma, Payer, Hospital), (Non-Profit: Govt)] & Region - Global Forecast to 2030

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 MARKET SCOPE
  • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 LIMITATIONS
• 1.6 STAKEHOLDERS
• 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Breakdown of primary sources
• 2.2 RESEARCH METHODOLOGY DESIGN
• 2.3 MARKET SIZE ESTIMATION
• 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.5 RESEARCH ASSUMPTIONS
  • 2.5.1 MARKET SIZING ASSUMPTIONS
  • 2.5.2 OVERALL STUDY ASSUMPTIONS
• 2.6 RISK ASSESSMENT
• 2.7 RESEARCH LIMITATIONS
  • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.7.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 PATIENT REGISTRY SOFTWARE MARKET OVERVIEW
• 4.2 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT & REGION
• 4.3 PATIENT REGISTRY SOFTWARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 PATIENT REGISTRY SOFTWARE MARKET: DEVELOPED VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 MARKET DYNAMICS
    • 5.2.1.1 Rising burden of chronic and rare diseases
    • 5.2.1.2 Shift toward value-based and patient-centered care
    • 5.2.1.3 Expansion of real-world evidence (RWE) and post-marketing surveillance needs
    • 5.2.1.4 Increasing use of digital health technologies and interoperable EHRs
    • 5.2.1.5 Government and regulatory incentives for registry implementation
  • 5.2.2 MARKET RESTRAINTS
    • 5.2.2.1 Shortage of trained and skilled resources
    • 5.2.2.2 High implementation and maintenance costs
  • 5.2.3 MARKET OPPORTUNITIES
    • 5.2.3.1 Expansion of population health management and outcomes tracking
    • 5.2.3.2 Rising demand for pregnancy and congenital anomaly registries for maternal-fetal safety monitoring
    • 5.2.3.3 Growing preference for subscription-based deployment models
  • 5.2.4 MARKET CHALLENGES
    • 5.2.4.1 Privacy- and data security-related concerns
    • 5.2.4.2 Reluctance to adopt advanced patient registry solutions
    • 5.2.4.3 Limited awareness among healthcare stakeholders
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.4 INDUSTRY TRENDS
  • 5.4.1 STRENGTHENED FUNDING FOR PATIENT-CENTERED RESEARCH AND RARE DISEASE REGISTRIES
  • 5.4.2 RISE IN AUTOMATED DATA ENTRY AND REGISTRY INTELLIGENCE
  • 5.4.3 CLOUD-BASED REGISTRIES AND DECENTRALIZED ACCESS
• 5.5 ECOSYSTEM ANALYSIS
• 5.6 VALUE CHAIN ANALYSIS
• 5.7 TECHNOLOGY ANALYSIS
  • 5.7.1 KEY TECHNOLOGIES
    • 5.7.1.1 Electronic data capture (EDC) systems
    • 5.7.1.2 Cloud computing & SaaS architecture
    • 5.7.1.3 Data privacy & security technologies
  • 5.7.2 COMPLEMENTARY TECHNOLOGIES
    • 5.7.2.1 Electronic health record (EHR) systems
    • 5.7.2.2 Clinical trial management systems (CTMS)
  • 5.7.3 ADJACENT TECHNOLOGIES
    • 5.7.3.1 Digital therapeutics (DTx) platforms
    • 5.7.3.2 Wearable devices & remote monitoring tools
    • 5.7.3.3 Blockchain for health data management
• 5.8 REGULATORY ANALYSIS
  • 5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.8.2 REGULATORY LANDSCAPE
    • 5.8.2.1 North America
    • 5.8.2.2 Europe
    • 5.8.2.3 Asia Pacific
    • 5.8.2.4 Middle East & Africa
    • 5.8.2.5 Latin America
• 5.9 PRICING ANALYSIS
  • 5.9.1 AVERAGE COST OF PATIENT REGISTRY SOFTWARE, BY END USER (2024)
  • 5.9.2 INDICATIVE PRICE OF PATIENT REGISTRY SOFTWARE, BY REGION (2024)
• 5.10 PORTER'S FIVE FORCES ANALYSIS
  • 5.10.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.10.2 BARGAINING POWER OF BUYERS
  • 5.10.3 THREAT OF SUBSTITUTES
  • 5.10.4 THREAT OF NEW ENTRANTS
  • 5.10.5 BARGAINING POWER OF SUPPLIERS
• 5.11 PATENT ANALYSIS
  • 5.11.1 PATENT PUBLICATION TRENDS FOR PATIENT REGISTRY SOFTWARE MARKET
  • 5.11.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR PATIENT REGISTRY SOFTWARE
  • 5.11.3 MAJOR PATENTS IN PATIENT REGISTRY SOFTWARE MARKET
• 5.12 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.12.2 KEY BUYING CRITERIA
• 5.13 END-USER ANALYSIS
  • 5.13.1 UNMET NEEDS
  • 5.13.2 END-USER EXPECTATIONS
• 5.14 KEY CONFERENCES & EVENTS, 2025-2026
• 5.15 CASE STUDY ANALYSIS
• 5.16 INVESTMENT & FUNDING SCENARIO
• 5.17 BUSINESS MODEL ANALYSIS
• 5.18 IMPACT OF AI/GEN AI ON PATIENT REGISTRY SOFTWARE MARKET
  • 5.18.1 TOP USE CASES & MARKET POTENTIAL
  • 5.18.2 KEY USE CASES
  • 5.18.3 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
    • 5.18.3.1 Case study: AI-powered data summarization improves registry utilization efficiency
  • 5.18.4 ELECTRONIC HEALTH RECORD (EHR) MARKET
  • 5.18.5 REAL WORLD EVIDENCE (RWE) MARKET
  • 5.18.6 USER READINESS AND IMPACT ASSESSMENT
    • 5.18.6.1 User readiness
      • 5.18.6.1.1 Hospitals & research networks
    • 5.18.6.2 Impact assessment
      • 5.18.6.2.1 Hospitals & academic research institutes
        • 5.18.6.2.1.1 Implementation
        • 5.18.6.2.1.2 Impact
• 5.19 IMPACT OF 2025 US TARIFFS ON PATIENT REGISTRY SOFTWARE MARKET
  • 5.19.1 INTRODUCTION
  • 5.19.2 KEY TARIFF RATES
  • 5.19.3 PRICE IMPACT ANALYSIS
    • 5.19.3.1 Cloud hosting infrastructure
    • 5.19.3.2 AI & analytics modules
    • 5.19.3.3 Offshore development & support services
  • 5.19.4 IMPACT ON COUNTRY/REGION
    • 5.19.4.1 US
    • 5.19.4.2 Europe
    • 5.19.4.3 Asia Pacific
  • 5.19.5 IMPACT ON END-USE INDUSTRIES
    • 5.19.5.1 For-profit registries
    • 5.19.5.2 Nonprofit registries
    • 5.19.5.3 Government & third-party administrators
    • 5.19.5.4 Others

6 PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE

• 6.1 INTRODUCTION
• 6.2 DISEASE REGISTRIES
  • 6.2.1 DIABETES REGISTRIES
    • 6.2.1.1 Need to monitor disease prevalence, treatment adherence, and long-term complications to boost adoption
  • 6.2.2 CARDIOVASCULAR REGISTRIES
    • 6.2.2.1 Ability of cardiovascular registries to enable healthcare systems to benchmark care quality and identify treatment gaps to boost growth
  • 6.2.3 CANCER REGISTRIES
    • 6.2.3.1 Critical tools for understanding cancer epidemiology and evaluating screening programs to drive market
  • 6.2.4 RARE DISEASE REGISTRIES
    • 6.2.4.1 Essential tools for advancing knowledge about rare diseases to support market growth
  • 6.2.5 ASTHMA REGISTRIES
    • 6.2.5.1 Improving asthma management and reducing exacerbations to fuel growth
  • 6.2.6 CHRONIC KIDNEY REGISTRIES
    • 6.2.6.1 Ability of registries to collect detailed data on disease progression, lab results, and treatment adherence to boost adoption
  • 6.2.7 ORTHOPEDIC REGISTRIES
    • 6.2.7.1 Ability to monitor implant performance, surgical outcomes, and complication rates to drive growth
  • 6.2.8 IMMUNIZATION REGISTRIES
    • 6.2.8.1 Strengthening vaccine coverage and safety monitoring to propel market
  • 6.2.9 BIRTH DEFECT REGISTRIES
    • 6.2.9.1 Need to track and prevent congenital anomalies through birth defect registries to propel market growth
  • 6.2.10 OTHER DISEASE REGISTRIES
• 6.3 PRODUCT REGISTRIES
  • 6.3.1 MEDICAL DEVICE REGISTRIES
    • 6.3.1.1 Ability of these registries to enhance safety, performance monitoring, and regulatory compliance to boost growth
  • 6.3.2 DRUG REGISTRIES
    • 6.3.2.1 Ability to support long-term safety, real-world evidence, and optimal therapy use to propel growth

7 PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT

• 7.1 INTRODUCTION
• 7.2 DIRECT-TO-PATIENT (PATIENT-RECORDED) REGISTRIES
  • 7.2.1 INCREASING PATIENT ENGAGEMENT AND DEMAND FOR SELF-REPORTED DATA TO BOOST MARKET GROWTH
• 7.3 SITE-BASED/CLINICAL DATA (PROVIDER-RECORDED) REGISTRIES
  • 7.3.1 GROWING NEED FOR ACCURATE, CLINICIAN-VERIFIED DATA AND SEAMLESS EHR INTEGRATION TO SUPPORT GROWTH

8 PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE

• 8.1 INTRODUCTION
• 8.2 MEDICAL RESEARCH & CLINICAL STUDIES
  • 8.2.1 GROWING NEED TO LEVERAGE REGISTRIES TO ENHANCE REAL-WORLD EVIDENCE AND CLINICAL TRIAL EFFICIENCY TO FUEL GROWTH
• 8.3 QUALITY IMPROVEMENT
  • 8.3.1 ADVANTAGES SUCH AS EVIDENCE-BASED PRACTICE AND PERFORMANCE BENCHMARKING TO DRIVE SEGMENTAL GROWTH
• 8.4 PATIENT CARE MANAGEMENT
  • 8.4.1 ABILITY TO EMPOWER PROACTIVE CHRONIC DISEASE MANAGEMENT THROUGH CENTRALIZED REGISTRIES TO SUPPORT GROWTH
• 8.5 POPULATION HEALTH
  • 8.5.1 EXPANDING ROLE OF PATIENT MANAGEMENT SYSTEMS IN DRIVING DIGITAL TRANSFORMATION TO CONTRIBUTE TO GROWTH
• 8.6 POINT-OF-CARE SUPPORT
  • 8.6.1 NEED FOR PERSONALIZED TREATMENT PLANS AND SHARED DECISION-MAKING TO DRIVE EFFICIENCY AND QUALITY IN HEALTHCARE
• 8.7 PUBLIC HEALTH SURVEILLANCE
  • 8.7.1 ABILITY OF REGISTRIES TO ENHANCE PREPAREDNESS AND RESPONSE CAPABILITIES TO DRIVE SEGMENTAL GROWTH
• 8.8 PATIENT SELF-CARE
  • 8.8.1 GROWING EMPHASIS ON PATIENT EMPOWERMENT AND SELF-MANAGEMENT TO PROPEL GROWTH
• 8.9 PATIENT ENGAGEMENT
  • 8.9.1 ADVANTAGES SUCH AS BETTER DATA ACCURACY AND MORE MEANINGFUL OUTCOMES TO BOOST GROWTH
• 8.10 OTHER USE CASES

9 PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT

• 9.1 INTRODUCTION
• 9.2 ON-PREMISE MODELS
  • 9.2.1 GROWING DEMAND FOR SECURITY, CONTROL, AND COMPLIANCE TO DRIVE MARKET GROWTH
• 9.3 CLOUD-BASED MODELS
  • 9.3.1 SCALABILITY, INTEROPERABILITY, AND COST-EFFECTIVENESS OF CLOUD-BASED MODELS TO DRIVE GROWTH

10 PATIENT REGISTRY SOFTWARE MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 FOR-PROFIT REGISTRIES
  • 10.2.1 PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDTECH COMPANIES
    • 10.2.1.1 Need for robust evidence generation, enhanced patient safety, and competitive differentiation to drive adoption
  • 10.2.2 HEALTHCARE PAYERS
    • 10.2.2.1 Need to improve population health management, control costs, and assess treatment value to drive demand
  • 10.2.3 HEALTHCARE PROVIDERS
    • 10.2.3.1 Hospitals
      • 10.2.3.1.1 Ability of registries to help hospitals collect detailed data on procedures, outcomes, and complications to boost market
    • 10.2.3.2 Clinics & outpatient settings
      • 10.2.3.2.1 Ability of registries to enable data-driven decision-making and streamlined documentation to drive demand
    • 10.2.3.3 Other healthcare providers
• 10.3 NONPROFIT REGISTRIES
  • 10.3.1 MEDICAL SPECIALTY SOCIETIES
    • 10.3.1.1 Advantages such as defined best practices and improved care delivery to propel growth
  • 10.3.2 PATIENT ORGANIZATIONS
    • 10.3.2.1 Importance of facilitating clinical trial recruitment and fostering collaboration with researchers to support growth
• 10.4 GOVERNMENT & THIRD-PARTY ADMINISTRATORS
  • 10.4.1 ABILITY OF GOVERNMENT-RUN REGISTRIES TO EVALUATE SUCCESS OF HEALTHCARE INITIATIVES TO FUEL MARKET
• 10.5 OTHER END USERS

11 PATIENT REGISTRY SOFTWARE MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 11.2.2 US
    • 11.2.2.1 US to dominate global market for patient registry software
  • 11.2.3 CANADA
    • 11.2.3.1 Government investment, collaborative initiatives, and strong push to standardize rare disease registries to drive growth
• 11.3 EUROPE
  • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 11.3.2 UK
    • 11.3.2.1 Growing incidence of cancer to drive market growth
  • 11.3.3 GERMANY
    • 11.3.3.1 National rollout of e-patient files and rare disease registries to strengthen patient care and research
  • 11.3.4 FRANCE
    • 11.3.4.1 Growing patient registry adoption with national data platforms and rare disease initiatives to support market growth
  • 11.3.5 ITALY
    • 11.3.5.1 Growing number of national networks and disease-specific registries to drive growth
  • 11.3.6 SPAIN
    • 11.3.6.1 Growing need to address rising chronic and cardiovascular disease prevalence to drive adoption
  • 11.3.7 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 11.4.2 JAPAN
    • 11.4.2.1 Japan's aging population and advanced digital strategies to drive growth in patient registry software market
  • 11.4.3 CHINA
    • 11.4.3.1 Robust national registries and expanding pharmaceutical approvals to drive patient registry software market
  • 11.4.4 INDIA
    • 11.4.4.1 Digital health advances to boost India's patient registry software market
  • 11.4.5 REST OF ASIA PACIFIC
• 11.5 LATIN AMERICA
  • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 11.5.2 BRAZIL
    • 11.5.2.1 Brazil to dominate patient registry software market in Latin America
  • 11.5.3 MEXICO
    • 11.5.3.1 Increase in focus of digital health to boost market growth
  • 11.5.4 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 11.6.2 GCC COUNTRIES
    • 11.6.2.1 Rising healthcare investments to fuel uptake
  • 11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT REGISTRY SOFTWARE MARKET
• 12.3 REVENUE ANALYSIS, 2020-2024
• 12.4 MARKET SHARE ANALYSIS, 2024
• 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 12.5.1 STARS
  • 12.5.2 EMERGING LEADERS
  • 12.5.3 PERVASIVE PLAYERS
  • 12.5.4 PARTICIPANTS
  • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 12.5.5.1 Company footprint
    • 12.5.5.2 Region footprint
    • 12.5.5.3 Product footprint
    • 12.5.5.4 Use case footprint
    • 12.5.5.5 Registry type footprint
    • 12.5.5.6 Deployment footprint
    • 12.5.5.7 End-user footprint
• 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 12.6.1 PROGRESSIVE COMPANIES
  • 12.6.2 RESPONSIVE COMPANIES
  • 12.6.3 DYNAMIC COMPANIES
  • 12.6.4 STARTING BLOCKS
  • 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 12.6.5.1 Detailed list of key startups/SMEs
    • 12.6.5.2 Competitive benchmarking of startups/Smes
• 12.7 COMPANY VALUATION & FINANCIAL METRICS
  • 12.7.1 FINANCIAL METRICS
  • 12.7.2 COMPANY VALUATION
• 12.8 BRAND/SOFTWARE COMPARISON
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT LAUNCHES, APPROVALS, UPGRADES, AND ENHANCEMENTS
  • 12.9.2 DEALS
  • 12.9.3 OTHER DEVELOPMENTS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 IBM
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Product enhancements
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Right to win
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses & competitive threats
  • 13.1.2 IQVIA HOLDINGS INC.
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Deals
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Right to win
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses & competitive threats
  • 13.1.3 HEALTH CATALYST, INC.
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Product approvals
      • 13.1.3.3.2 Deals
      • 13.1.3.3.3 Other developments
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Right to win
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses & competitive threats
  • 13.1.4 ORACLE
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Deals
    • 13.1.4.4 MnM view
      • 13.1.4.4.1 Right to win
      • 13.1.4.4.2 Strategic choices
      • 13.1.4.4.3 Weaknesses & competitive threats
  • 13.1.5 UNITEDHEALTH GROUP
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Deals
    • 13.1.5.4 MnM view
      • 13.1.5.4.1 Right to win
      • 13.1.5.4.2 Strategic choices
      • 13.1.5.4.3 Weaknesses & competitive threats
  • 13.1.6 CONDUENT INCORPORATED
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Deals
  • 13.1.7 ELEKTA
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products offered
    • 13.1.7.3 Recent developments
      • 13.1.7.3.1 Deals
  • 13.1.8 NEC CORPORATION (NEC SOFTWARE SOLUTIONS UK LIMITED)
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products offered
  • 13.1.9 DASSAULT SYSTEMES (MEDIDATA)
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products offered
    • 13.1.9.3 Recent developments
      • 13.1.9.3.1 Product launches
      • 13.1.9.3.2 Deals
  • 13.1.10 EVIDENTIQ (DACIMA SOFTWARE INC.)
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products offered
    • 13.1.10.3 Recent developments
      • 13.1.10.3.1 DEALS
  • 13.1.11 MRO (FIGMD, INC.)
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products offered
    • 13.1.11.3 Recent developments
      • 13.1.11.3.1 Deals
      • 13.1.11.3.2 Other developments
  • 13.1.12 IMAGETREND
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products offered
    • 13.1.12.3 Recent developments
      • 13.1.12.3.1 Product upgrades
      • 13.1.12.3.2 Deals
  • 13.1.13 GLOBAL VISION TECHNOLOGIES, INC.
    • 13.1.13.1 Business overview
    • 13.1.13.2 Products offered
    • 13.1.13.3 Recent developments
      • 13.1.13.3.1 Other developments
  • 13.1.14 SYNEOS HEALTH
    • 13.1.14.1 Business overview
    • 13.1.14.2 Products offered
    • 13.1.14.3 Recent developments
      • 13.1.14.3.1 Deals
  • 13.1.15 VERADIGM LLC
    • 13.1.15.1 Business overview
    • 13.1.15.2 Products offered
    • 13.1.15.3 Recent developments
      • 13.1.15.3.1 Product launches
      • 13.1.15.3.2 Deals
  • 13.1.16 ESO
    • 13.1.16.1 Business overview
    • 13.1.16.2 Products offered
    • 13.1.16.3 Recent developments
      • 13.1.16.3.1 Deals
  • 13.1.17 ORDINAL DATA INC.
    • 13.1.17.1 Business overview
    • 13.1.17.2 Products offered
  • 13.1.18 CEDARON MEDICAL
    • 13.1.18.1 Business overview
    • 13.1.18.2 Products offered
  • 13.1.19 FIVOS HEALTH
    • 13.1.19.1 Business overview
    • 13.1.19.2 Products offered
    • 13.1.19.3 Recent developments
      • 13.1.19.3.1 Deals
  • 13.1.20 ACROSS HEALTHCARE
    • 13.1.20.1 Business overview
    • 13.1.20.2 Products offered
    • 13.1.20.3 Recent developments
      • 13.1.20.3.1 Deals
• 13.2 OTHER PLAYERS
  • 13.2.1 VERANA HEALTH
  • 13.2.2 PULSE INFOFRAME INC.
  • 13.2.3 AMPLITUDE CLINICAL OUTCOMES
  • 13.2.4 NPHASE, INC. (REDCAP CLOUD)
  • 13.2.5 OM1

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS

List of Tables

• TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
• TABLE 2 FACTOR ANALYSIS
• TABLE 3 RISK ASSESSMENT: PATIENT REGISTRY SOFTWARE MARKET
• TABLE 4 PATIENT REGISTRY SOFTWARE MARKET: IMPACT ANALYSIS
• TABLE 5 HEALTHCARE DATA BREACHES IN US
• TABLE 6 PATIENT REGISTRY SOFTWARE MARKET: ROLE IN ECOSYSTEM
• TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 8 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 10 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 11 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 12 REGULATORY SCENARIO OF NORTH AMERICA
• TABLE 13 REGULATORY SCENARIO OF EUROPE
• TABLE 14 REGULATORY SCENARIO OF ASIA PACIFIC
• TABLE 15 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA
• TABLE 16 REGULATORY SCENARIO OF LATIN AMERICA
• TABLE 17 AVERAGE COST OF PATIENT REGISTRY SOFTWARE, BY END USER (ORDINAL HEALTH INC.) (2024)
• TABLE 18 INDICATIVE PRICE RANGE OF PATIENT REGISTRY SOFTWARE, BY REGION (2024)
• TABLE 19 PATIENT REGISTRY SOFTWARE MARKET: PORTER'S FIVE FORCES ANALYSIS
• TABLE 20 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR PATIENT REGISTRY SOFTWARE
• TABLE 21 PATIENT REGISTRY SOFTWARE MARKET: LIST OF PATENTS/PATENT APPLICATIONS
• TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%)
• TABLE 23 KEY BUYING CRITERIA FOR TOP THREE END USERS
• TABLE 24 UNMET NEEDS IN PATIENT REGISTRY SOFTWARE MARKET
• TABLE 25 END-USER EXPECTATIONS IN PATIENT REGISTRY SOFTWARE MARKET
• TABLE 26 PATIENT REGISTRY SOFTWARE MARKET: KEY CONFERENCES & EVENTS, 2025-2026
• TABLE 27 CASE STUDY 1: CANCER REGISTRY IMPLEMENTATION WITH DACIMA CLINICAL SUITE
• TABLE 28 CASE STUDY 2: ENHANCING REAL-WORLD EVIDENCE WITH CASTOR RWE
• TABLE 29 CASE STUDY 3: DEVICE DATA INTEGRATION USING MEDIREPORT 360
• TABLE 30 US-ADJUSTED RECIPROCAL TARIFF RATES
• TABLE 31 PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023-2030 (USD MILLION)
• TABLE 32 PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 33 PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 34 PATIENT REGISTRY SOFTWARE MARKET FOR DIABETES REGISTRIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 35 PATIENT REGISTRY SOFTWARE MARKET FOR CARDIOVASCULAR REGISTRIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 36 PATIENT REGISTRY SOFTWARE MARKET FOR CANCER REGISTRIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 37 PATIENT REGISTRY SOFTWARE MARKET FOR RARE DISEASE REGISTRIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 38 PATIENT REGISTRY SOFTWARE MARKET FOR ASTHMA REGISTRIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 39 PATIENT REGISTRY SOFTWARE MARKET FOR CHRONIC KIDNEY REGISTRIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 40 PATIENT REGISTRY SOFTWARE MARKET FOR ORTHOPEDIC REGISTRIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 41 PATIENT REGISTRY SOFTWARE MARKET FOR IMMUNIZATION REGISTRIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 42 PATIENT REGISTRY SOFTWARE MARKET FOR BIRTH DEFECT REGISTRIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 43 PATIENT REGISTRY SOFTWARE MARKET FOR OTHER DISEASE REGISTRIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 44 PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 45 PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 46 PATIENT REGISTRY SOFTWARE MARKET FOR MEDICAL DEVICE REGISTRIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 47 PATIENT REGISTRY SOFTWARE MARKET FOR DRUG REGISTRIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 48 PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 49 PATIENT REGISTRY SOFTWARE MARKET FOR DIRECT-TO-PATIENT (PATIENT-RECORDED) REGISTRIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 50 PATIENT REGISTRY SOFTWARE MARKET FOR SITE-BASED/CLINICAL DATA (PROVIDER-RECORDED) REGISTRIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 51 PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023-2030 (USD MILLION)
• TABLE 52 PATIENT REGISTRY SOFTWARE MARKET FOR MEDICAL RESEARCH & CLINICAL STUDIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 53 PATIENT REGISTRY SOFTWARE MARKET FOR QUALITY IMPROVEMENT, BY REGION, 2023-2030 (USD MILLION)
• TABLE 54 PATIENT REGISTRY SOFTWARE MARKET FOR PATIENT CARE MANAGEMENT, BY REGION, 2023-2030 (USD MILLION)
• TABLE 55 PATIENT REGISTRY SOFTWARE MARKET FOR POPULATION HEALTH, BY REGION, 2023-2030 (USD MILLION)
• TABLE 56 PATIENT REGISTRY SOFTWARE MARKET FOR POINT-OF-CARE SUPPORT, BY REGION, 2023-2030 (USD MILLION)
• TABLE 57 PATIENT REGISTRY SOFTWARE MARKET FOR PUBLIC HEALTH SURVEILLANCE, BY REGION, 2023-2030 (USD MILLION)
• TABLE 58 PATIENT REGISTRY SOFTWARE MARKET FOR PATIENT SELF-CARE, BY REGION, 2023-2030 (USD MILLION)
• TABLE 59 PATIENT REGISTRY SOFTWARE MARKET FOR PATIENT ENGAGEMENT, BY REGION, 2023-2030 (USD MILLION)
• TABLE 60 PATIENT REGISTRY SOFTWARE MARKET FOR OTHER USE CASES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 61 PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
• TABLE 62 PATIENT REGISTRY SOFTWARE MARKET FOR ON-PREMISE MODELS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 63 PATIENT REGISTRY SOFTWARE MARKET FOR CLOUD-BASED MODELS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 64 PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 65 PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 66 PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 67 PATIENT REGISTRY SOFTWARE MARKET FOR PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDTECH COMPANIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 68 PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PAYERS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 69 PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 70 PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 71 PATIENT REGISTRY SOFTWARE MARKET FOR HOSPITALS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 72 PATIENT REGISTRY SOFTWARE MARKET FOR CLINICS & OUTPATIENT SETTINGS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 73 PATIENT REGISTRY SOFTWARE MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 74 PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 75 PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 76 PATIENT REGISTRY SOFTWARE MARKET FOR MEDICAL SPECIALTY SOCIETIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 77 PATIENT REGISTRY SOFTWARE MARKET FOR PATIENT ORGANIZATIONS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 78 PATIENT REGISTRY SOFTWARE MARKET FOR GOVERNMENT & THIRD-PARTY ADMINISTRATORS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 79 PATIENT REGISTRY SOFTWARE MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 80 PATIENT REGISTRY SOFTWARE MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 81 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 82 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 83 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023-2030 (USD MILLION)
• TABLE 84 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023-2030 (USD MILLION)
• TABLE 85 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 86 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 87 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
• TABLE 88 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 89 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 90 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 91 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 92 US: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 93 US: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023-2030 (USD MILLION)
• TABLE 94 US: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023-2030 (USD MILLION)
• TABLE 95 US: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 96 US: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 97 US: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
• TABLE 98 US: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 99 US: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 100 US: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 101 US: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 102 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 103 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023-2030 (USD MILLION)
• TABLE 104 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023-2030 (USD MILLION)
• TABLE 105 CANADA: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 106 CANADA: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 107 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
• TABLE 108 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 109 CANADA: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 110 CANADA: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 111 CANADA: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 112 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 113 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 114 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023-2030 (USD MILLION)
• TABLE 115 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023-2030 (USD MILLION)
• TABLE 116 EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 117 EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 118 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
• TABLE 119 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 120 EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 121 EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 122 EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 123 UK: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 124 UK: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023-2030 (USD MILLION)
• TABLE 125 UK: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023-2030 (USD MILLION)
• TABLE 126 UK: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 127 UK: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 128 UK: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
• TABLE 129 UK: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 130 UK: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 131 UK: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 132 UK: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 133 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 134 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023-2030 (USD MILLION)
• TABLE 135 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023-2030 (USD MILLION)
• TABLE 136 GERMANY: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 137 GERMANY: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 138 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
• TABLE 139 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 140 GERMANY: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 141 GERMANY: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 142 GERMANY: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 143 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 144 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023-2030 (USD MILLION)
• TABLE 145 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023-2030 (USD MILLION)
• TABLE 146 FRANCE: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 147 FRANCE: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 148 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
• TABLE 149 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 150 FRANCE: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 151 FRANCE: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 152 FRANCE: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 153 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 154 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023-2030 (USD MILLION)
• TABLE 155 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023-2030 (USD MILLION)
• TABLE 156 ITALY: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 157 ITALY: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 158 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
• TABLE 159 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 160 ITALY: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 161 ITALY: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 162 ITALY: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 163 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 164 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023-2030 (USD MILLION)
• TABLE 165 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023-2030 (USD MILLION)
• TABLE 166 SPAIN: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 167 SPAIN: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 168 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
• TABLE 169 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 170 SPAIN: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 171 SPAIN: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 172 SPAIN: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 173 REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 174 REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023-2030 (USD MILLION)
• TABLE 175 REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023-2030 (USD MILLION)
• TABLE 176 REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 177 REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 178 REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
• TABLE 179 REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 180 REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 181 REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 182 REST OF EUROPE: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 183 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 184 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 185 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023-2030 (USD MILLION)
• TABLE 186 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023-2030 (USD MILLION)
• TABLE 187 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 188 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 189 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
• TABLE 190 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 191 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 192 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 193 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 194 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 195 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023-2030 (USD MILLION)
• TABLE 196 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023-2030 (USD MILLION)
• TABLE 197 JAPAN: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 198 JAPAN: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 199 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
• TABLE 200 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 201 JAPAN: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 202 JAPAN: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 203 JAPAN: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 204 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 205 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023-2030 (USD MILLION)
• TABLE 206 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023-2030 (USD MILLION)
• TABLE 207 CHINA: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 208 CHINA: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 209 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
• TABLE 210 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 211 CHINA: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 212 CHINA: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 213 CHINA: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 214 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 215 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023-2030 (USD MILLION)
• TABLE 216 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023-2030 (USD MILLION)
• TABLE 217 INDIA: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 218 INDIA: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 219 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
• TABLE 220 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 221 INDIA: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 222 INDIA: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 223 INDIA: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 224 REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 225 REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023-2030 (USD MILLION)
• TABLE 226 REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023-2030 (USD MILLION)
• TABLE 227 REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 228 REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 229 REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
• TABLE 230 REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 231 REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 232 REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 233 REST OF ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 234 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 235 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 236 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023-2030 (USD MILLION)
• TABLE 237 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023-2030 (USD MILLION)
• TABLE 238 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 239 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 240 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
• TABLE 241 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 242 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 243 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 244 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 245 BRAZIL: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 246 BRAZIL: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023-2030 (USD MILLION)
• TABLE 247 BRAZIL: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023-2030 (USD MILLION)
• TABLE 248 BRAZIL: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 249 BRAZIL: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 250 BRAZIL: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
• TABLE 251 BRAZIL: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 252 BRAZIL: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 253 BRAZIL: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 254 BRAZIL: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 255 MEXICO: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 256 MEXICO: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023-2030 (USD MILLION)
• TABLE 257 MEXICO: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023-2030 (USD MILLION)
• TABLE 258 MEXICO: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 259 MEXICO: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 260 MEXICO: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
• TABLE 261 MEXICO: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 262 MEXICO: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 263 MEXICO: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 264 MEXICO: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 265 REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 266 REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023-2030 (USD MILLION)
• TABLE 267 REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023-2030 (USD MILLION)
• TABLE 268 REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 269 REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 270 REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
• TABLE 271 REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 272 REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 273 REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 274 REST OF LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 275 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 276 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 277 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023-2030 (USD MILLION)
• TABLE 278 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023-2030 (USD MILLION)
• TABLE 279 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 280 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 281 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
• TABLE 282 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 283 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 284 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 285 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 286 GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 287 GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023-2030 (USD MILLION)
• TABLE 288 GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023-2030 (USD MILLION)
• TABLE 289 GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 290 GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 291 GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
• TABLE 292 GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 293 GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 294 GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 295 GCC COUNTRIES: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 296 REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
• TABLE 297 REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2023-2030 (USD MILLION)
• TABLE 298 REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2023-2030 (USD MILLION)
• TABLE 299 REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR DISEASE REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 300 REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 301 REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
• TABLE 302 REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 303 REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR FOR-PROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 304 REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 305 REST OF MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET FOR NONPROFIT REGISTRIES, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 306 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT REGISTRY SOFTWARE MARKET, JANUARY 2022-JUNE 2025
• TABLE 307 PATIENT REGISTRY SOFTWARE MARKET: DEGREE OF COMPETITION
• TABLE 308 PATIENT REGISTRY SOFTWARE MARKET: REGION FOOTPRINT
• TABLE 309 PATIENT REGISTRY SOFTWARE MARKET: PRODUCT FOOTPRINT
• TABLE 310 PATIENT REGISTRY SOFTWARE MARKET: USE CASE FOOTPRINT
• TABLE 311 PATIENT REGISTRY SOFTWARE MARKET: REGISTRY TYPE FOOTPRINT
• TABLE 312 PATIENT REGISTRY SOFTWARE MARKET: DEPLOYMENT FOOTPRINT
• TABLE 313 PATIENT REGISTRY SOFTWARE MARKET: END-USER FOOTPRINT
• TABLE 314 PATIENT REGISTRY SOFTWARE MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
• TABLE 315 PATIENT REGISTRY SOFTWARE MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY PRODUCT AND REGION
• TABLE 316 PATIENT REGISTRY SOFTWARE MARKET: PRODUCT LAUNCHES, APPROVALS, UPGRADES, AND ENHANCEMENTS, JANUARY 2022-JUNE 2025
• TABLE 317 PATIENT REGISTRY SOFTWARE MARKET: DEALS, JANUARY 2022-JUNE 2025
• TABLE 318 PATIENT REGISTRY SOFTWARE MARKET: OTHER DEVELOPMENTS, JANUARY 2022-JUNE 2025
• TABLE 319 IBM: COMPANY OVERVIEW
• TABLE 320 IBM: PRODUCTS OFFERED
• TABLE 321 IBM: PRODUCT ENHANCEMENTS, JANUARY 2022-JUNE 2025
• TABLE 322 IQVIA HOLDINGS INC.: COMPANY OVERVIEW
• TABLE 323 IQVIA HOLDINGS INC.: PRODUCTS OFFERED
• TABLE 324 IQVIA HOLDINGS INC.: DEALS, JANUARY 2022-JUNE 2025
• TABLE 325 HEALTH CATALYST, INC.: COMPANY OVERVIEW
• TABLE 326 HEALTH CATALYST, INC.: PRODUCTS OFFERED
• TABLE 327 HEALTH CATALYST, INC.: PRODUCT APPROVALS, JANUARY 2022-JUNE 2025
• TABLE 328 HEALTH CATALYST, INC.: DEALS, JANUARY 2022-JUNE 2025
• TABLE 329 HEALTH CATALYST, INC.: OTHER DEVELOPMENTS, JANUARY 2022-JUNE 2025
• TABLE 330 ORACLE: COMPANY OVERVIEW
• TABLE 331 ORACLE: PRODUCTS OFFERED
• TABLE 332 ORACLE: DEALS, JANUARY 2022-JUNE 2025
• TABLE 333 UNITEDHEALTH GROUP: COMPANY OVERVIEW
• TABLE 334 UNITEDHEALTH GROUP: PRODUCTS OFFERED
• TABLE 335 UNITEDHEALTH GROUP: DEALS, JANUARY 2022-JUNE 2025
• TABLE 336 CONDUENT INCORPORATED: COMPANY OVERVIEW
• TABLE 337 CONDUENT INCORPORATED: PRODUCTS OFFERED
• TABLE 338 CONDUENT INCORPORATED: DEALS, JANUARY 2022-JUNE 2025
• TABLE 339 ELEKTA: COMPANY OVERVIEW
• TABLE 340 ELEKTA: PRODUCTS OFFERED
• TABLE 341 ELEKTA: DEALS, JANUARY 2022-JUNE 2025
• TABLE 342 NEC CORPORATION (NEC SOFTWARE SOLUTIONS UK LIMITED): COMPANY OVERVIEW
• TABLE 343 NEC CORPORATION (NEC SOFTWARE SOLUTIONS UK LIMITED): PRODUCTS OFFERED
• TABLE 344 DASSAULT SYSTEMES (MEDIDATA): COMPANY OVERVIEW
• TABLE 345 DASSAULT SYSTEMES (MEDIDATA): PRODUCTS OFFERED
• TABLE 346 DASSAULT SYSTEMES (MEDIDATA): PRODUCT LAUNCHES, JANUARY 2022-JUNE 2025
• TABLE 347 DASSAULT SYSTEMES (MEDIDATA): DEALS, JANUARY 2022-JUNE 2025
• TABLE 348 EVIDENTIQ (DECIMA SOFTWARE INC.): COMPANY OVERVIEW
• TABLE 349 EVIDENTIQ (DECIMA SOFTWARE INC.): PRODUCTS OFFERED
• TABLE 350 EVIDENTIQ (DECIMA SOFTWARE INC.): DEALS, JANUARY 2022-JUNE 2025
• TABLE 351 MRO (FIGMD, INC.): COMPANY OVERVIEW
• TABLE 352 MRO (FIGMD, INC.): PRODUCTS OFFERED
• TABLE 353 MRO (FIGMD, INC.): DEALS, JANUARY 2022-JUNE 2025
• TABLE 354 MRO (FIGMD, INC.): OTHER DEVELOPMENTS, JANUARY 2022-JUNE 2025
• TABLE 355 IMAGETREND: COMPANY OVERVIEW
• TABLE 356 IMAGETREND: PRODUCTS OFFERED
• TABLE 357 IMAGETREND: PRODUCT UPGRADES, JANUARY 2022-JUNE 2025
• TABLE 358 IMAGETREND: DEALS, JANUARY 2022-JUNE 2025
• TABLE 359 GLOBAL VISION TECHNOLOGIES, INC.: COMPANY OVERVIEW
• TABLE 360 GLOBAL VISION TECHNOLOGIES, INC.: PRODUCTS OFFERED
• TABLE 361 GLOBAL VISION TECHNOLOGIES, INC.: OTHER DEVELOPMENTS , JANUARY 2022-JUNE 2025
• TABLE 362 SYNEOS HEALTH: COMPANY OVERVIEW
• TABLE 363 SYNEOS HEALTH: PRODUCTS OFFERED
• TABLE 364 SYNEOS HEALTH: DEALS, JANUARY 2022-JUNE 2025
• TABLE 365 VERADIGM LLC: COMPANY OVERVIEW
• TABLE 366 VERADIGM LLC: PRODUCTS OFFERED
• TABLE 367 VERADIGM LLC: PRODUCT LAUNCHES, JANUARY 2022-JUNE 2025
• TABLE 368 VERADIGM LLC: DEALS, JANUARY 2022-JUNE 2025
• TABLE 369 ESO: COMPANY OVERVIEW
• TABLE 370 ESO: PRODUCTS OFFERED
• TABLE 371 ESO: DEALS, JANUARY 2022-JUNE 2025
• TABLE 372 ORDINAL DATA, INC.: COMPANY OVERVIEW
• TABLE 373 ORDINAL DATA, INC.: PRODUCTS OFFERED
• TABLE 374 CEDARON MEDICAL: COMPANY OVERVIEW
• TABLE 375 CEDARON MEDICAL: PRODUCTS OFFERED
• TABLE 376 FIVOS HEALTH: COMPANY OVERVIEW
• TABLE 377 FIVOS HEALTH: PRODUCTS OFFERED
• TABLE 378 FIVOS HEALTH: DEALS, JANUARY 2022-JUNE 2025
• TABLE 379 ACROSS HEALTHCARE: COMPANY OVERVIEW
• TABLE 380 ACROSS HEALTHCARE: PRODUCTS OFFERED
• TABLE 381 ACROSS HEALTHCARE: DEALS, JANUARY 2022-JUNE 2025

List of Figures

• FIGURE 1 PATIENT REGISTRY SOFTWARE MARKET SEGMENTATION & REGIONAL SCOPE
• FIGURE 2 RESEARCH DESIGN
• FIGURE 3 PRIMARY SOURCES
• FIGURE 4 INSIGHTS FROM INDUSTRY EXPERTS
• FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
• FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
• FIGURE 7 SUPPLY-SIDE MARKET ESTIMATION
• FIGURE 8 PATIENT REGISTRY SOFTWARE MARKET: REVENUE ESTIMATION APPROACH
• FIGURE 9 BOTTOM-UP APPROACH: END-USER SPENDING ON PATIENT REGISTRY SOFTWARE
• FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025-2030)
• FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
• FIGURE 12 TOP-DOWN APPROACH
• FIGURE 13 DATA TRIANGULATION METHODOLOGY
• FIGURE 14 PATIENT REGISTRY SOFTWARE MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
• FIGURE 15 PATIENT REGISTRY SOFTWARE MARKET, BY USE CASE, 2025 VS. 2030 (USD MILLION)
• FIGURE 16 PATIENT REGISTRY SOFTWARE MARKET, BY REGISTRY TYPE, 2025 VS. 2030 (USD MILLION)
• FIGURE 17 PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT, 2025 VS. 2030 (USD MILLION)
• FIGURE 18 PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
• FIGURE 19 PATIENT REGISTRY SOFTWARE MARKET: GEOGRAPHICAL SNAPSHOT
• FIGURE 20 GROWING DEMAND FOR REAL-WORLD EVIDENCE, INTEROPERABILITY, AND REGULATORY COMPLIANCE TO DRIVE MARKET GROWTH
• FIGURE 21 SITE-BASED/CLINICAL DATA (PROVIDER-RECORDED) REGISTRIES IN NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARE IN 2025
• FIGURE 22 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
• FIGURE 23 GROWTH RATES OF EMERGING ECONOMIES TO BE HIGHER THAN THOSE OF DEVELOPED ECONOMIES DURING FORECAST PERIOD
• FIGURE 24 PATIENT REGISTRY SOFTWARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• FIGURE 26 PATIENT REGISTRY SOFTWARE MARKET: ECOSYSTEM ANALYSIS
• FIGURE 27 PATIENT REGISTRY SOFTWARE MARKET: VALUE CHAIN ANALYSIS
• FIGURE 28 PATIENT REGISTRY SOFTWARE MARKET: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 29 GLOBAL PATENT PUBLICATION TRENDS IN PATIENT REGISTRY SOFTWARE, 2015-2025
• FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR "PATIENT REGISTRY SOFTWARE" PATENTS (JANUARY 2015-JUNE 2025)
• FIGURE 31 MAJOR PATENTS IN PATIENT REGISTRY SOFTWARE MARKET (JANUARY 2015-JUNE 2025)
• FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
• FIGURE 33 KEY BUYING CRITERIA FOR TOP THREE END USERS
• FIGURE 35 MARKET POTENTIAL OF AI/GENERATIVE AI IN ENHANCING PATIENT REGISTRY SOFTWARE ACROSS INDUSTRIES
• FIGURE 36 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
• FIGURE 37 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET SNAPSHOT
• FIGURE 38 EUROPE: PATIENT REGISTRY SOFTWARE MARKET SNAPSHOT
• FIGURE 39 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET SNAPSHOT
• FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN PATIENT REGISTRY SOFTWARE MARKET, 2020-2024 (USD MILLION)
• FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PATIENT REGISTRY SOFTWARE MARKET (2024)
• FIGURE 42 PATIENT REGISTRY SOFTWARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
• FIGURE 43 PATIENT REGISTRY SOFTWARE MARKET: COMPANY FOOTPRINT
• FIGURE 44 PATIENT REGISTRY SOFTWARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
• FIGURE 45 EV/EBITDA OF KEY VENDORS
• FIGURE 46 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
• FIGURE 47 PATIENT REGISTRY SOFTWARE MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS
• FIGURE 48 IBM: COMPANY SNAPSHOT (2024)
• FIGURE 49 IQVIA HOLDINGS INC.: COMPANY SNAPSHOT (2024)
• FIGURE 50 HEALTH CATALYST, INC.: COMPANY SNAPSHOT (2024)
• FIGURE 51 ORACLE: COMPANY SNAPSHOT (2024)
• FIGURE 52 UNITEDHEALTH GROUP: COMPANY SNAPSHOT (2024)
• FIGURE 53 CONDUENT INCORPORATED: COMPANY SNAPSHOT (2024)
• FIGURE 54 ELEKTA: COMPANY SNAPSHOT (2024)
• FIGURE 55 NEC CORPORATION (NEC SOFTWARE SOLUTIONS UK LIMITED): COMPANY SNAPSHOT
• FIGURE 56 DASSAULT SYSTEMES (MEDIDATA): COMPANY SNAPSHOT (2024)
• FIGURE 57 VERADIGM LLC: COMPANY SNAPSHOT (2022)